Treatment Of Cancers With Immunostimulatory Hiv Tat Derivative Polypeptides

Abstract

Disclosed herein are methods of treating cancer by administering a modified Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) polypeptide with increased immunostimulatory properties relative to the non-modified Tat polypeptide.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 8, 2015
  • Application: Aug 19, 2013
    US US 201313969917 A
  • Priority: Aug 19, 2013
    US US 201313969917 A
  • Priority: Mar 23, 2010
    US US 73004310 A
  • Priority: Mar 3, 2010
    US US 31022110 P
  • Priority: Feb 19, 2010
    US US 30627810 P
  • Priority: Mar 23, 2009
    US US 16260509 P

Download Citation


Sign in to the Lens

Feedback